ST凯利：11月20日召开董事会会议

Group 1 - ST凯利 held its 13th meeting of the 6th board of directors on November 20, 2025, discussing the investment in 动之医学技术 (Shanghai) Co., Ltd. and related transactions [1] - For the year 2024, ST凯利's revenue composition is as follows: 56.82% from medical device manufacturing, 26.48% from instrument disinfection services, 14.48% from medical device trading, and 2.21% from other businesses [1] - As of the report date, ST凯利 has a market capitalization of 4.1 billion yuan [1]